The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive (CROSBI ID 241951)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Juričić, Gordana ; Saračević, Andrea ; Milevoj Kopčinović, Lara ; Bakliža, Ana ; Šimundić, Ana- Maria
engleski
The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive
Citrate buffer additive has been suggested to be of supreme performance in inhibiting glycolysis. However, there is little evidence in the literature regarding the comparability of glucose concentrations in liquid and lyophilized citrate buffer containing tubes. The aim of this study was to compare glucose concentrations in tubes containing liquid (Glucomedics) and lyophilized citrate buffer (Terumo VENOSAFE™ Glycemia) additive, measured immediately after centrifugation.
Diabetes ; Glucomedics ; Glycolysis inhibitors ; Preanalytical phase ; Venosafe Glycemia
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
49 (18)
2016.
1402-1405
objavljeno
0009-9120
10.1016/j.clinbiochem.2016.03.006
Povezanost rada
Kliničke medicinske znanosti, Farmacija